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Abstract 
Aims: To determine the most frequently utilized functional status assessment instruments for patients with brain 
tumors, compare their contents, using the International Classification of Functioning, Disability and Health (ICF), and 
their psychometric properties.
Methods: A scoping review was conducted to explore possible assessment instruments and summarize the evi-
dence. A systematic literature search was performed for identification of the frequently used functional assessment 
tool in clinical trials in PubMed, ScienceDirect, and ProQuest databases. The content of most used instruments was 
linked to the ICF categories. The psychometric qualities of these assessment tools were systematically searched and 
analyzed.
Results: Nine most used assessment tools in clinical trials were identified. The most frequently used assessment 
instrument is the Karnofsky Performance Scale, which is developed for a general assessment of oncological patients. 
Out of four self-assessment tools, two were disease-specific (EORTC QLQ-BN20 and FACT-Br), EORTC QLQ-C30 has 
been shown good psychometric properties in patients with brain tumors as well as in patients with various oncologi-
cal diseases, similar to the SF-36, it is used in patients with brain tumors as well as in patients with various diseases. 
The Functional Independence Measure and the Barthel Index were two objective assessment tools that described 
functioning, but two were neuropsychological tests (MMSE and Trial Making Test). Two hundred eighty-three mean-
ingful concepts were identified and linked to 102 most relevant second-level categories covering all components of 
the ICF. Forty-nine studies reporting psychometric properties of those nine assessment tools were identified, indicat-
ing good reliability and validity for all the instruments.
Conclusion: Nine most frequently utilized functional status assessment instruments for patients with brain tumors 
represent all components of the ICF and have good psychometric properties. However, the choice of the tool 
depends on the clinical question posed and the aim of its use.
Keywords: International Classification of Functioning, Disability and Health (ICF), Linking, Psychometric properties, 
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Introduction
Based on 2015 statistics, patients with brain tumors 
make up a total of 5% of all oncology patients in Lat-
via [1]. As the medical industry, diagnostic capabilities, 
and technologies for treating primary tumors evolve, 
the survival rates for individuals diagnosed with pri-
mary brain tumors have increased significantly [1, 2]. 
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Tumor localization, anatomical distribution, and volume 
are determinants before and after primary treatment. 
The most common symptoms for brain tumors usually 
include headache, nausea, vomiting, partial and gener-
alized seizures, cognitive impairment, and ataxia. These 
symptoms may also arise from common treatment strate-
gies used for brain tumor patients such as chemotherapy, 
radiation therapy, and surgery. It is estimated that  75% 
of all patients with brain tumors show symptoms of focal 
neurological deficiency [3], which greatly affects one’s 
level of functioning, as well as the quality of life.
Numerous articles discuss the role of rehabilitation in 
tumor cases, while others discuss the positive effects of 
rehabilitation for patients with brain tumors compared to 
patients with stroke or after a traumatic brain injury [4, 
5]. All of these articles demonstrate positive outcomes in 
restoring functioning [6, 7]. Bartolo M. et al. have dem-
onstrated that rehabilitation is very effective if initiated as 
early as possible after primary treatment for brain tumor 
patients [5].
To assess the rehabilitation needs and outcomes for this 
population, a specific functional disability assessment 
tool is necessary [8]. The use of appropriate assessment 
tools could improve rehabilitation planning that in turn 
would lead to better outcomes, including patients’ quality 
of life. Currently, no standardized protocols are provided 
for evaluation of persons with brain tumors. The Interna-
tional Classification of Functioning, Disability and Health 
(ICF) provides a framework for coding large-scale health 
information, a common standardized language for iden-
tifying and comparing functional assessment tools, and 
provides valuable information to develop an evidence-
based standardized evaluation protocol for patients with 
brain tumor [9].
The aim of this study was to determine the most fre-
quently utilized functional assessment instruments for 
patients with brain tumors, compare their contents, using 
the International Classification of Functioning, Disability 
and Health, and analyze their psychometric properties.
Methods
Identification of assessment tools
A scoping review was conducted according to Joanna 
Briggs institute guidelines [10]. PubMed, ScienceDirect, 
and ProQuest databases were searched (last updated 
August 2020) for publications since 2000 using the fol-
lowing keywords: “brain neoplasm” or “meningioma” or 
“glioblastoma” or “intracranial neoplasm” or “brain can-
cer” or “outcome assessment” or “treatment outcome” 
or functional outcome mentioned in the title/abstract. 
Studies referring in the title or abstract to assessment 
tools used to assess people diagnosed with brain tumors 
older than 18  years were included. Original research 
studies randomized controlled clinical trials, observa-
tional studies, cross-sectional studies, qualitative studies 
were included in which authors reported using a tool to 
assess functioning in persons with brain tumors. Studies 
were included even if the tool was not initially designed 
to assess functioning. Studies were excluded if they 
addressed genetic, laboratory, and animal research. Sys-
tematic reviews, secondary analyses of published data, 
validity studies, protocols, letters, were also excluded 
from this report. All searches were limited to journal arti-
cles written in English; the search results were compiled 
in the reference management system EndNote where 
duplicates were removed. A summary of the search pro-
cedure is shown in Fig. 1.
Data collection was based on the Joanna Briggs Insti-
tute Manual for Evidence Synthesis Chapter 11.2 Devel-
opment of a Scoping Review protocol [10]. General study 
data (year of publication, country, study design), available 
data on participants (number, diagnosis), and assessment 
tools used in the study were recorded. Assessment tools 
that were used in more than 9% of all studies the scop-
ing review using frequency analysis. The choice of this 
cut-off point was based on the distribution of frequen-
cies as well as on substantive considerations of the list of 
instruments.
Linking to the ICF
All assessment instruments identified in the study meet-
ing selection criteria were classified using the ICF linking 
guidelines. The ICF linking guidelines state that before 
starting the process of linking health-status measures to 
the ICF categories, identification of all meaningful con-
cepts within each item of the health status measure needs 
to be performed. According to the rules, the interval of 
time cannot be linked to the ICF, also, if a meaningful 
concept of an item is explained by examples, both the 
concept and the examples are to be linked, while tech-
nical measures can be linked by defining the purpose 
and then linking it with the ICF category [11, 12]. Two 
independent medical professionals (authors LG and SS) 
separately identified the meaningful concepts within the 
analyzed instruments and linked them to the ICF con-
cepts. The raters met and discussed any discrepancies to 
achieve a consensus classification for the instruments and 
GB served as a third rater, in case the consensus could not 
be reached. Identified categories within each of the ana-
lyzed instruments were organized according to the struc-
ture of the ICF. Further, the content of the instruments 
was compared to identify categories that overlap between 
the instruments and those that are unique for specific 
tools. The perspective adopted in health information and 
categorization of response for self-assessment tools were 
also reported [11].
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Psychometric properties
Following the search methodology developed by PubMed 
[13], the electronic database MEDLINE (PubMed) was 
searched for studies that reflect the psychometric prop-
erties of a particular assessment tool. First, a search was 
performed using a diagnosis-specific MeSH terms and 
key words identified in the search methodology and the 
names of assessment tools. Headline screening identified 
studies that reflected one of the psychometric proper-
ties of a given instrument (reliability: internal coherence; 
test/retest method, evaluator reliability. Validity: content 
validity; criterion validity; construct validity) specific 
to patients with brain tumors. If psychometric proper-
ties for chosen assessment tools were not identified, the 
search was repeated excluding diagnosis-specific MeSH 
terms, thus conducting a search for studies covering dif-
ferent diagnoses. Headline screening then identified 
studies that reflected one of the psychometric properties 
of a given instrument for various diagnoses. The interpre-
tation of the psychometric properties is given in Table 1.
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Results
Identification of assessment tools
The initial search strategy returned 9721 articles. The 
duplicates were removed, titles and summaries were 
revised, following the exclusion of articles that did not 
meet the selection criteria, in result 56 articles were 
included in the scoping review.
To make the search as comprehensive as possible, ref-
erences from the 56 included articles were studied and 
an additional 32 articles were included after applying the 
selection criteria.
As a result, a total of 88 studies were included in the 
report; 31 were administered in the United States, 42 in 
Europe (8 in Italy, 8 in the Netherlands, 6 in Norway, 4 
in France, Germany and England each 3, Austria, Tur-
key, Sweden 2 studies each, Poland, Switzerland, Den-
mark, and Finland each 1), 2 in Australia, 7 in Canada, 
and 4 in Asian countries (Korea, Israel, Iran). The stud-
ies look at groups of patients with various brain tumor 
diagnoses. The 74 articles included patients with primary 
tumors, of which 26 were diagnosed with glioma, 3- oli-
godendroglioma, 1- oligoastrocytoma, 3- astrocytoma, 
4- adenoma, 1- meningioma, 1 case study had a mixed 
group with patients suffering from meningioma and glio-
blastomas. 28 of the studies did not categorize patients by 
their histologic type; instead, patients with primary brain 
tumors were evaluated. 9 studies evaluated patients with 
secondary brain tumors or with brain metastases. In 4 of 
the included studies, the functional abilities of patients 
with brain tumors are compared to those of a stroke 
patient or a patient with a brain injury.
All instruments mentioned in the articles were identi-
fied, yielding 86 assessment tools which are summarized 
in Additional file  1. According to research methodol-
ogy, 9 assessment tools that were used in more than 9% 
of the research articles included in the study were used 
for further analysis: A list of these instruments, their 
abbreviations, and the number of articles that have used 
that instrument are summarized in Table 2. Out of nine 
instruments included in the study,
two are specific for patients with brain tumors: ORTC 
Quality of Life Questionnaire-Brain Neoplasm 20 
(EORTC QLQ-BN20), Functional Assessment of Can-
cer Therapy-Brain (FACT-Br), one is specific for patients 
with oncological diseases—Karnofsky Performance Scale 
(KPS), four: Mini-mental State Examination (MMSE), 
Functional Independence Measure (FIM), Trial Making 
Test (TMT), Barthel Index (BI) and 36-Item Short Form 
Health Survey (SF-36)) are used for patients with various 
diagnoses. The EORTC Quality of Life Questionnaire 30 
(EORTC QLQ-C30) has been shown to be valid, reliable, 
and responsive in patients with brain tumors as well as 
in patients with various oncological diseases. Similar, to 
the 36-item Short Form Health Survey (SF-36), it is used 
in patients with brain tumors as well as in patients with 
various diseases.
Table 1 The interpretation of the psychometric properties
Cronbach’s ɑ, Chronbach’s ɑ coefficient; ICC, interclass correlation coefficient
Reliability
Internal reliability + Cronbach’s ɑ or ICC ≥ 0.70
− Cronbach’s ɑ or ICC < 0.70
Test/retest method + ICC ≥ 0.70 or Pearson correlation coefficient/ Spearman rank correlation coefficient ≥ 0.80
- ICC < 0.70 or Pearson correlation coefficient/Spearman rank correlation coefficient < 0.80
Interrater reliability + ICC ≥ 0.70 or Pearson correlation coefficient/ Spearman rank correlation coefficient ≥ 0.80
− ICC < 0.70 or Pearson correlation coefficient/Spearman rank correlation coefficient < 0.80
Validity
Content validity + The content of the assessment instrument is adequate, comprehensive, questions and tasks chosen to adequately reflect the 
content to be evaluated
- Not all selected questions and tasks reflect the content, content is not relevant, comprehensive
Criterion validity + Significant and stable relation between measurement and another instrument (r ≥ 0.70) or with start/end measurement
− Poor measurement correlation with another instrument (r < 0.70) or start / end measurement
Structural validity + Correlation with instruments measuring the same ≥ 0.50 or correlation higher for unrelated elements in the instrument than 
for unrelated ones
- Correlation with instruments measuring the same < 0.50 or correlation with related elements in the instrument is lower than 
unrelated ones
Responsiveness
Responsiveness + Able to detect clinically significant changes over time
− Cannot detect clinically significant changes over time
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Linking to the ICF
In total, 283 meaningful concepts were identified within 
all nine assessment instruments and linked to 394 most 
precise categories of the ICF. The detailed description of 
the linking is shown in Table 3. In two cases, the mean-
ingful concepts could be linked most precisely to the 
component of Activities and Participation. In 12 cases, 
it was the first  level or chapter under the component of 
Activities and Participation. The content of the assess-
ment tools was linked to 102 most relevant second-level 
categories of the ICF in total. Thirty-four of these catego-
ries were under the component of Body Functions and 
Table 2 The most frequently used assessment instruments
Assessment instrument Abbreviation N of studies mentioned Frequency (%)
Karnofsky Performance Scale KPS 42 48
Mini-Mental State Examination MMSE 20 23
EORTC Quality of Life Questionnaire-Core 30 EORTC QLQ-C30 18 20
EORTC Quality of Life Questionnaire-Brain Neoplasm 20 EORTC QLQ-BN20 15 17
Functional Independence Measure FIM 13 15
Trail Making Test TMT 13 15
Barthel Index BI 9 10
Functional Assessment of Cancer Therapy-Brain FACT-BR 8 9
36-Item Short Form Health Survey SF-36 8 9
Table 3 Summary of linking the nine most frequently used assessment tools to the ICF
Desc, descriptive; Dep, dependency; Appr, appraisal; Int, intensity; NC, not covered; ND, not definable
KPS MMSE EORTC QLQ-C30 EORTC 
QLQ-BN20
FIM TMT BI FACT-BR SF-36
N of meaningful concepts 32 11 42 22 19 NA 32 63 62
N of categories identified 71 18 52 29 31 16 39 66 72
N of unique categories identified 22 15 39 19 29 16 22 52 27
Perspective Desc Desc Appr Appr Dep Desc Dep Appr Appr
Categorization Int Int Int Int
Body functions
2nd level 4 9 7 3 6 2 16 4
3d and 4th level 10 6 6 1 5
Body structures
2nd level 2
Activities and participation 1 1
1st level 1 5 2 4
2nd level 4 15 5 20 9 8 17 6
3d level 1 4 1 3 5 1 12
Environmental factors
2nd level 13 9 1 7
3d level 3
Not classified
Nc-health condition 6 2 2
Nc-Quality of life 1 2 13 5
Nd-general health 1 2 6
Nd-physical health 3 1 2
Nd-mental health 2
Nd-disability 2
Personal factors 1 1 2
Page 6 of 18Ģiga et al. Health Qual Life Outcomes          (2021) 19:234 
Structures, 50 – under Activities and Participation, and 
18 – Environmental Factors. Detailed comparison of the 
content between assessment tools are shown in Tables 4, 
5,  and 6 for components of Body Functions and Struc-
tures, Activities and Participation and Environmental 
Factors, respectively. No appropriate ICF category was 
found for 54 items following the ICF linking guidelines.
Evaluating all 9 assessment tools, the most related ICF 
categories in the body function domain were b140 atten-
tion functions (n = 5), b144 memory functions (n = 4), 
b156 perceptual functions (n = 4), b280 sensation of pain 
(n = 4) and b730 muscle power functions (n = 4). FACT-
BR, BN-20 and MMSE contained most concepts related 
to the Body functions and Structures. Five out of nine 
analyzed assessment tools included concepts on d450 
walking and d540 dressing. The BN-20 questionnaire 
contained meaningful concepts that could be linked to 
23  s level categories of the Activities and Participation, 
covering all domains of this component. FIM was linked 
to 21 categories that did not cover chapters of Major life 
areas and Community, social and civic life.
Psychometric properties
For psychometric properties that are specific for brain 
tumor diagnosis, search in PubMed yielded 578 results 
for KPS, 18 for MMSE, 55 for EORTC QLQ-C30, 6 for 
EORTC QLQ-BN20, 5 for FIM, 36 for TMT, 14 for BI, 
21 for FACT-Br, and 4 for SF-36. Headline screening 
resulted in identifying 1 study for EORTC QLQ-C30, 4 
studies for EORTC QLQ-BN20, 3 studies for FACT- Br, 
and 1 study for SF-36. A search strategy for various diag-
noses was implemented for the remaining assessment 
instruments as well as SF-36 and EORTC QLQ-C30 due 
to the  previous search strategy yielding only 1 result. 
As a result, for further analysis, 4 articles for KPS, 5 for 
MMSE, 1 + 5 for EORTC QLQ-C30, 4 for EORTC QLQ-
BN20, 10 for FIM, 2 for TMT, 7 for BI 3 for FACT-Br, and 
8 for SF-36 were included in this review. The psychomet-
ric properties for assessment instruments EORTC QLQ-
C30, EORTC QLQ-BN20, FACT-Br, and SF-36, that are 
specific to brain tumor diagnosis are summarized in 
Table 7. The psychometric properties analyzed in mixed 
diagnosis studies for EORTC QLQ-C30, MMSE, SF-36, 
BI, FIM, KPS, TMT are summarized below, see Table 8.
Discussion
This study identified nine rehabilitation assessment 
instruments that have most commonly been referred to 
in the literature for adults with brain tumors, that cover 
all components of the ICF, and have good psychometric 
properties. As far as the authors are aware, this is the only 
scoping review of assessment instruments used for adults 
with brain tumors. However, this scoping review did not 
identify one unique assessment instrument for the target 
group. This patient group is specific in a way that there is 
no unifying patient-specific clinical set of symptoms and 
their symptoms depend on various other factors [14].
Five of these tools are used for objective assessment: 
KPS, MMSE, FIM, TMT, BI, four are self-assessment 
tools: FACT-Br, SF-36, EORTC QLQ-C30, EORTC QLQ- 
BN20. One of these tools (KPS) is used to assess physi-
cal activity, two (MMSE; TMT) are cognitive function 
assessment tools, FACT-Br, SF-36, EORTC QLQ-C30, 
EORTC QLQ-BN20 measures the  quality of life, and 
both, FIM and BI are used to assess disability.
The most frequently used assessment instrument is the 
Karnofsky Performance Scale as it is used as a criterion 
for the selection of participants by measuring their level 
of physical activity [15]. This assessment tool is devel-
oped for a  general assessment of oncological patients 
[16] and reflects the overall ability to perform usual daily 
activities (component of Activities and Participation of 
the ICF) in the context of help needed from other people 
(Environmental Factors).
Four of these instruments are used to evaluate patients 
with brain tumors: EORTC QLQ-C30; EORTC QLQ-
BN20; FACT-Br, SF-36; they are all linked to the quality 
of life. Moreover, the EORTC team recommends that 
EORTC QLQ-C30 and EORTC QLQ-BN20 tools be used 
together [17]. These two tools cover both functioning 
components of the ICF and from the perspective of con-
tent, complement each other. EORTC QLQ-C30 contains 
more specific questions on problems specific to patients 
with brain tumors [18, 19]. The EORTC QLQ-C30 and 
the EORTC QLQ-BN20 provide comprehensive infor-
mation about the patient’s quality of life, but this is often 
overlooked in studies identified in this scoping review. 
The FACT-Br questionnaire has been used less and it 
has as good properties in terms of intra-rater reliability 
and structural validity as other two specific quality of life 
measurements, contains problems that have not been 
included in any of the previous tools, and can clearly be 
important for this population, such as handling stress or 
driving a car. It also considers important Environmental 
factors, such as help and attitudes of family members and 
friends, as well as health professionals. Some important 
concepts also overlap with the SF-36 that have developed 
as a multipurpose tool that is used for assessment of 
functional health and well-being [20] and has also been 
widely used for patient-reported outcomes in popula-
tions with different diagnoses [21]. Therefore, this could 
be a  good choice to use the SF-36, if the comparison 
between populations is needed.
Between the most used assessment tools, the FIM and 
BI have been listed. These instruments are non-specific 
to diagnosis, and both have been widely used in different 
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Table 5 Content comparison of assessment tools linked to the component of Activities and Participation of the ICF





FIM TMT BI FACT-BR SF-36 Total
d1 Learning and applying knowledge xxx 1
d110 Watching x x 2
d115 Listening x 1
d160 Focusing attention x 1
d163 Thinking x 1
d166 Reading x x x x 4
d175 Solvingproblems x x 2
d177 Making decisions x 1
d2 General tasks and demands
d220 Undertaking multiple tasks x 1
d230 Carrying out daily routine x x 2
d240 Handling stress and other psychological demands x 1
d3 Communication x 1
d310 Communicating with receiving spoken messages x 1
d315 Communicating with receiving nonverbal messages x x 2
d320 Communicating with—receiving—formal sign 
language messages
x 1
d325 Communicating with—receiving—written messages x 1
d330 Speaking x x x 3
d335 Producing nonverbal messages x x 2
d340 Lifting and carrying objects x x 2
d345 Writing messages x x 2
d350 Conversation x 1
d4 Mobility x 1
d410 Changing basic body position x x 2
d415 Maintaining a body position x x x 3
d420 Transferring oneself xxx x 2
d430 Lifting and carrying objects xxx 1
d440 Fine hand use x 1
d455 Hand and arm use x 1
d450 Walking x x x xxx xxx 5
d455 Moving around x xxx xxx 3
d460 Moving around in different locations x 1
d465 Moving around using equipment x x 2
d475 Driving x 1
d5 Self-care xxx x 2
d510 Washing oneself x x x x 4
d520 Caring for body parts x xxx x 3
d530 Toileting x x x 3
d540 Dressing x x x x x 5
d550 Eating x x x x 4
d560 Drinking x 1
d598 Self-care 0
d6 Domestic life x x 2
d620 Acquisition of goods and services x 1
d7 Interpersonal interactions and relationships x x 2
d710 Basic interpersonal interactions x 1
d720 Complex interpersonal interactions x 1
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rehabilitation populations [22–24]. Both scales, the FIM 
and the BI, are performance-based assessment tools 
and both analyze the level of independence in the most 
important activities of daily living. Their psychometric 
properties have been profoundly analyzed, and the ceil-
ing effect for the BI can be observed when compared 
to the FIM [25]. However, the psychometric proper-
ties of the objective assessment instruments specific for 
the patient group have not been proven; therefore, their 
psychometric properties were demonstrated in patients 
suffering from stroke, traumatic brain injury (TBI), or 
similar neurological conditions. Interestingly, two neu-
ropsychological assessment tools (the MMSE and the 
TMT) are mentioned among the most frequently used 
for persons with brain tumors. It can be explained by the 
fact that cognitive impairments are a common symptom 
in patients with brain tumors [4]. Both instruments focus 
mostly on the cognitive functions of the component of 
the Body Functions and Structures of the ICF and both 
are performance-based. However, the psychometric 
properties of the MMSE have been better documented.
The International Classification of Functioning, Dis-
ability and Health (ICF) provides the  user with a broad 
spectrum of health outcomes, including physical and cog-
nitive functioning. By linking available assessment tools 
to this concept, it is possible to analyze the content of the 
available instruments and choose the appropriate one for 
the problem that is being measured and, consequently, 
treated [11, 12]. Using the ICF framework, it was pos-
sible to link most elements identified in the assessment 
instruments to certain categories. Some elements could 
not be linked since they covered topics such as quality 
of life, personal factors, or certain elements not defined 
in the ICF. Body Function categories were dominated 
by MMSE, TMT, EORTC QLQ-BN20, EORTC QLQ-
C30, activity and participation categories—FIM, BI, KPS, 
SF-36 but FACT-Br viewed these two domains equally. 
Environmental factors were assessed by EORTC QLQ-
30, FACT-Br, FIM, BI, and KPS. Given that the clinical 
picture of brain tumor patients is similar to that of other 
neurological conditions, such as stroke [6] or TBI [7], the 
ICF Core Sets were reviewed for stroke and TBI [26], and 
their categories were compared to categories identified in 
this scoping review. Comprehensive core sets for stroke 
listed 13 categories in body functions and structures, 
14 in activities and participation, and 23 categories in 
environmental factors that were not identified in assess-
ment instruments analyzed in this study. Comprehensive 
core sets for TBI listed 10 categories in body functions 
domain, 22 in activities and participation, and 28 catego-
ries in environmental factor domain that were not identi-
fied in any of 9 assessment instruments analyzed within 
this study. This can be explained by the fact that the most 
frequently used assessment instruments do not cover all 
the possible impairments for people with brain tumors.
Given that the ICF Core Sets for stroke and TBI were 
compared to categories identified in this review and they 
proved to be overall covering similar areas it can be con-
cluded that all 9 assessment tools identified in this study 
can be appropriate and specific assessment instruments 
for patients with brain tumors, as they have been proven 
valid, reliable, and responsive to a variety of neurological 
conditions. Further research is recommended to assess 
x = 1 or 2 items included, xxx = 3 or more items included
Table 5 (continued)





FIM TMT BI FACT-BR SF-36 Total
d750 Informal social relationships xxx 1
d760 Family relationships x x x x 4
d770 Intimate relationships x 1
d8 Major life areas x x 2
d840 Apprenticeship (work preparation) xxx x 2
d845 Acquiring, keeping and terminating a job xxx x 2
d850 Remunerative employment xxx x x x 4
d855 Non-remunerative employment xxx x 2
d870 Economic self-sufficiency x 1
d9 Community, social and civic life x x 2
d910 Community life x 1
d920 Recreation and leisure x x xxx 3
Total 6 1 23 6 21 9 10 19 16
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reliability, validity, and responsiveness of assessment 
instruments specifically for brain tumor patient groups.
Overall, the current study has a few limitations. First, 
the quality of the studies included in the scoping review 
was not assessed, as the purpose of the scoping review 
was to identify the most frequently used assessment 
instruments. Second, the authors included only nine out 
of 86 assessment tools for further analysis, which were 
used in more than 9% of the study articles included in the 
study. That runs the risk that this analysis of assessment 
instruments does not use some of the more recently 
developed assessment tools, which may be better suited 
for the specific patient group but are not used frequently 
enough in research articles to be included in the analysis.
Conclusions
Between the nine most frequently used assessment 
instruments in clinical studies, one was a generic tool for 
an  overall description of activity level for patients with 
diagnosis of cancer, three were diagnosis-specific self-
assessment tools, one was a multipurpose tool for assess-
ment of functionality and health status, two were widely 
used tools in rehabilitation for assessment of activities 
of daily living, and two were neurocognitive tests. These 
tools cover all components of the International Classi-
fication of Functioning, Disability and Health and have 
proven to have good psychometric properties; however, 
the assessment tools that are not diagnosis-specific, still 
must be validated for the brain tumor population.
Since the content and administration vary, the choice 
of the tool used for assessment of patients with brain 
tumor depends on the clinical question posed, as well as 
the aim of the use of this tool.
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